Evelien Nijssen
banner
eveliennijssen.bsky.social
Evelien Nijssen
@eveliennijssen.bsky.social
Marketing X Science | Head of Marketing @nvisionquantum.bsky.social | Passionate about translating complex tech into impact
Reposted by Evelien Nijssen
NVision’s quantum technology has arrived in Japan. 🇯🇵

Our first POLARIS deployment in the country is live at Hokkaido University, where Prof Shingo Matsumoto and his team will use quantum-enhanced MRI to study brain metabolism & disease response.

Learn more: www.nvision-quantum.com/news/nvision...
September 1, 2026 at 6:12 AM
Reposted by Evelien Nijssen
QuE-MRT is entering it's next phase 🚀

With funding extended through August 2028, the ~€20M project will continue advancing quantum-enhanced metabolic MRI toward clinical translation.

📽️ Hear from the consortium about what's next.

Learn more about QuE-MRT: www.nvision-quantum.com/news/que-mrt...
September 18, 2026 at 11:46 AM
Reposted by Evelien Nijssen
Excited to see our story on SWR!

While developing a molecule to make cancer metabolism visible with MRI, we discovered it could also serve as a qubit. Molecular qubits could be made stably & at scale, opening new possibilities for quantum computing.

🎥from 15:35 www.ardmediathek.de/video/swr-ak...?
August 14, 2026 at 8:45 PM
Reposted by Evelien Nijssen
Is the disease active? Is treatment working? Conventional MRI can miss important information because it shows only indirect consequences of inflammation.

Researchers at WashU are exploring how quantum-enhanced metabolic MRI with POLARIS could visualize disease activity and treatment response in MS.
July 22, 2026 at 3:17 PM
Reposted by Evelien Nijssen
NVision has been named to 2026 @fastcompany.com World Changing Ideas list for POLARIS, our quantum-enabled platform designed to make metabolic MRI scalable.

Standard MRI shows anatomy. POLARIS is designed to help make metabolism visible.

See the full list: www.fastcompany.com/world-changi...
June 16, 2026 at 11:13 AM
Reposted by Evelien Nijssen
What will it take for Europe to remain competitive in quantum?

Next week, our CEO @sellabrosh.bsky.social joins Jason Palmer from @economist.com to discuss the future of Europe's quantum ecosystem and the role of pioneering quantum computing architectures.

Commercialising Quantum Global | June 17
June 12, 2026 at 9:11 AM
Reposted by Evelien Nijssen
The biggest challenge in quantum computing? Moving from fragile, complex lab systems to qubits that can be manufactured, integrated, and scaled.

Peter Barrett from Playground Global explains why he believes NVision's PIQC molecular qubits could open a new path to scalable quantum computing.
June 8, 2026 at 1:22 PM
Reposted by Evelien Nijssen
“NVision is globally unique in their talent for manipulating quantum spins” - Peter Barrett, Playground Global

Peter explains why in this 3-minute video.

As one of our earliest investors, Peter has had a front-row seat to our evolution from #QuantumSensing to #QuantumComputing.
May 18, 2026 at 3:09 PM
Reposted by Evelien Nijssen
We believe scaling #QuantumComputing requires networking chips using photons. But the hardware didn't exist. Until now.

Unveiling PIQC: our new quantum molecular architecture designed to scale to 100k-qubit QPUs

Blog: www.nvision-quantum.com/news/piqc-wh...

Whitepaper: arxiv.org/abs/2605.21204
May 21, 2026 at 7:18 PM
Reposted by Evelien Nijssen
We are excited to welcome Dr. Prineha Narang, Professor of Physical Sciences and Electrical and Computer Engineering at UCLA, to NVision’s Scientific Advisory Board!

Get her take on how “NVision is taking a molecular approach to quantum computing” in this video.

#QuantumComputing #DeepTech
May 15, 2026 at 1:32 PM
Reposted by Evelien Nijssen
After years of work, we’re unveiling a molecular quantum system that points toward a fundamentally different path for quantum computing.

Our PIQC “Pixie” architecture combines long-lived matter qubits with a native photonic interface all in one molecule.

arXiv paper: arxiv.org/abs/2605.10077
May 14, 2026 at 10:12 AM
Reposted by Evelien Nijssen
Two major milestones for NVision today:

We raised a $55M Series B led by Abbott and are expanding our quantum platform into quantum computing.

POLARIS: Quantum-enhanced metabolic MRI

PIQC “Pixie”: A new molecular quantum computing platform

Learn more: nvision-quantum.com/news/series-b-piqc
May 13, 2026 at 10:05 AM
Reposted by Evelien Nijssen
Join us tonight for EMIM 2026 Bar Hopping Night!

Stop by our bar to collect:
🍹free drink vouchers
🎉 our HP MRI Study Group badge - wear it with pride and show you’re part of the HP MRI community

We’re looking forward to a hypercharged evening. See you there!
March 24, 2026 at 10:01 AM
Reposted by Evelien Nijssen
NVision lands in Denmark!

We’ve secured a €5.4M grant with @au.dk to bring our tech to the clinic for early liver cancer detection.

The goal: Use quantum-enhanced MRI to detect serious disease earlier and monitor treatment effects more precisely than ever before 🚀

Read more: shorturl.at/oLr9M
NVision and Aarhus University Awarded Innovation Fund Denmark Grant to Advance Clinical Translation of Quantum-Enhanced MRI | Corporate - EQS News
shorturl.at
March 16, 2026 at 10:07 AM
Reposted by Evelien Nijssen
Excited to sponsor THINC 2026 in Munich on March 23!

Can real-time metabolic imaging with hyperpolarized 13C #MRI add true value to treatment decisions? Join us at @tum.de to find out.

Register: thinc.day 🚀

#MetabolicImaging #MedTech #HyperpolarizedMRI
March 12, 2026 at 2:03 PM
Reposted by Evelien Nijssen
NVision has landed in Cambridge! 🇬🇧✈️ We are partnering with Cambridge University'’s Dept of Radiology.

Together, we're establishing a translational pipeline to move quantum-enhanced metabolic MRI into the clinic, focusing on early metabolic shifts in Liver Cancer and MS. 🔬🧠

Learn more 👇
Cambridge | NVision Imaging
www.nvision-imaging.com
March 3, 2026 at 8:57 AM
Reposted by Evelien Nijssen
Standardizing 13C Metabolic #MRI for Multi-Site Research.

We are excited to introduce a robust, open-source reference phantom for carbon-13 metabolic MRI that we developed in collaboration with Ulm University.

Read the full paper here: link.springer.com/article/10.1...
Design and chemical composition of a reference phantom for 13C metabolic MRSI - Magnetic Resonance Materials in Physics, Biology and Medicine
Object Development of a reproducible and long-term stable reference phantom for 13C metabolic MRSI, addressing the need for accessible calibration and quality assurance tools across sites and platform...
link.springer.com
February 27, 2026 at 12:20 PM
Reposted by Evelien Nijssen
Looking forward to connecting at ISMRM Benelux this Friday!

If you’re attending, come by our booth to discover POLARIS and exchange ideas on hyperpolarized 13C MRI.
January 28, 2026 at 10:10 AM
Reposted by Evelien Nijssen
Honored to present Dr. Oliver Sartor (East Jefferson General Hospital / Tulane Urology) as our scientific advisor!

His world-renowned expertise in #ProstateCancer & clinical #DrugDevelopment will be invaluable for advancing the clinical translation of our metabolic imaging technology.
January 14, 2026 at 7:10 PM
Reposted by Evelien Nijssen
Research Update: Extended hyperpolarized pyruvate delivery maintains the lactate signal, bringing the #HPMRI community closer to pseudo–steady-state metabolism. This approach could lead to more robust and higher-resolution clinical 13C imaging.

Paper: pubmed.ncbi.nlm.nih.gov/41219687/
December 3, 2025 at 12:09 PM
Reposted by Evelien Nijssen
Honored to present Prof. Glenn Bauman (@lhsccanada.bsky.social / @westernu.ca) as member of our Scientific Advisory Board!

His expertise in #RadiationOncology & Image-Guided Radiotherapy (IGRT) will be invaluable for advancing the clinical translation of our novel metabolic imaging #biomarkers.
December 4, 2025 at 2:03 PM
Reposted by Evelien Nijssen
QuE-MRT General Assembly success! 60+ partners aiming to make quantum-enhanced #MetabolicMRI a clinical reality for guiding cancer treatment.

Progress made:
⚙️ Standardized MRI acquisition protocols
🧪 New, exciting probes
📋 Regulatory steps in Germany

Funded by BMBF.
October 31, 2025 at 3:15 PM
Reposted by Evelien Nijssen
#Quantum Meets #AI!🚀
NVision hosted the inaugural Q-AID workshop in Ulm.

Our mission: Integrate quantum-enhanced MRI & AI to transform diagnosis and treatment monitoring of cancer, Alzheimer's & MS through metabolic imaging.

Learn more here: www.nvision-imaging.com/q-aid
November 12, 2025 at 7:32 AM
Reposted by Evelien Nijssen
The future of metabolic imaging is mobilizing!⚡

We're proud to support #THINC 2026 (Munich, March 23) — a forum to explore how metabolic imaging with 13C HP-MRI can add true value in guiding treatment decisions.

Subscribe for updates here: thinc.day
October 24, 2025 at 1:22 PM
Reposted by Evelien Nijssen
🎀What if we could diagnose #breastcancer earlier, and see if treatment works in days, not months?

At NVision we are working to make it possible — to help people live longer, healthier lives🩷

#BreastCancerAwarenessMonth
October 30, 2025 at 5:53 PM